Blood Transfusions for Pregnancy Loss in Texas Before and After Abortion Bans, 2017‒2023
American Journal of Public Health · 2025-11 · 115 (11) · 1887-1894
DOI: 10.2105/ajph.2025.308224 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Public Health, 2025-11. Verfasst von Amanda Nagle und 3 weiteren Autor:innen. Beteiligte Einrichtung: Amanda Nagle is with the Population Research Center at the University of Texas at Austin. Goleen Samari is with the Department of Population and Publ…. Hauptthemen laut MEDLINE: Blood Transfusion, Abortion, Spontaneous, Abortion, Induced. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS.
Abstract (Originalsprache)
Objectives
To measure changes in blood transfusion related to pregnancy loss in Texas after the 2021 Senate Bill 8 (SB8), which banned abortion after the detection of fetal cardiac activity (6-week ban), and the ban that was enforced after the 2022 Dobbs v Jackson Supreme Court decision, which banned abortion at all gestational durations (total ban).
Methods
We used administrative data from all Texas hospital, emergency, and ambulatory surgical facilities from January 2017 through September 2023. Using time series analysis, we assessed if the number of pregnancy loss encounters that received blood transfusions, an indicator of severe morbidity, was different than expected after the 6-week and total bans.
Results
We identified 320 696 pregnancy loss encounters and 7408 related blood transfusions. During the 6-week ban, transfusion numbers were similar to expected. During the total ban, the quarterly mean number of pregnancy loss encounters that received blood transfusions was 385.8, which was 50.7 more transfusions (15.1%) than the 335.1 expected based on historical data (2-sample t test P = .03).
Conclusions
Texas’s total abortion ban was associated with an increase in severe morbidity among people experiencing pregnancy loss. ( Am J Public Health. 2025;115(11):1887–1894. https://doi.org/10.2105/AJPH.2025.308224 )
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Amanda Nagle is with the Population Research Center at the University of Texas at Austin. Goleen Samari is with the Department of Population and Public Health Sciences in the Keck School of Medicine of the University of…
ORCID-Profile: Amanda Nagle, Goleen Samari, Lauren Thaxton, Alison Gemmill
Förderung
- NICHD NIH HHS
Zitieren
APA
Nagle, A., Samari, G., Thaxton, L., & Gemmill, A. (2025). Blood Transfusions for Pregnancy Loss in Texas Before and After Abortion Bans, 2017‒2023. American Journal of Public Health, 115(11), 1887-1894. https://doi.org/10.2105/ajph.2025.308224
Vancouver
Nagle A, Samari G, Thaxton L, Gemmill A. Blood Transfusions for Pregnancy Loss in Texas Before and After Abortion Bans, 2017‒2023. American Journal of Public Health. 2025;115(11):1887-1894. doi:10.2105/ajph.2025.308224
BibTeX
@article{Nagle2025,
author = {Nagle, Amanda and Samari, Goleen and Thaxton, Lauren and Gemmill, Alison},
title = {Blood Transfusions for Pregnancy Loss in Texas Before and After Abortion Bans, 2017‒2023},
journal = {American Journal of Public Health},
year = {2025},
volume = {115},
number = {11},
pages = {1887--1894},
doi = {10.2105/ajph.2025.308224}
}
EUVIMED